Sonali Chopra

With over two decades of experience and leadership across 50+ disease areas, Sonali brings a unique lens to the evolving role of patient advocacy in pharma. As regulatory pressures and expectations shift, her team is focused on advancing health equity, amplifying the voices of the “invisible patient,” and reshaping how advocacy integrates with broader commercial and policy goals. This session will explore how advocacy leaders are navigating new legislative dynamics, building scalable patient strategies, and collaborating with stakeholders—from cancer advocates to federal agencies—to drive meaningful, inclusive impact. Expect a forward-looking conversation on the intersection of policy, access, and patient-first innovation.